19 Aug 2022 --- A study conducted by Cedars-Sinai Medical Center reveals a new method to detect gut microbes that activate immune cells and help identify the cause of inflammatory diseases. Published in the Journal of Science Translational Medicine, the diseases targeted are obesity, inflammatory bowel disease, cancer, liver disease and certain neurological diseases by using a protein in the blood, the human serum.
